Home > Insider Trading > Filing (0001543077-18-000002)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1105533	Argos Therapeutics Inc	ARGS	Pharmaceutical Preparations (2834)	562110007

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1543077	D Jeffrey Abbey	Argos Therapeutics, Inc. 4233 Technology Drive Durham NC 27704	President, Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-01-03	114,702	$0.16	635,033	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares reported represent an amount sold to cover the tax liabilities of the reporting person pursuant to a 10b5-1 sales instruction related to a restricted stock award agreement dated August 30, 2017. Acquisition of the restricted stock was previously reported in Table I of the reporting person's Form 4 on August 31, 2017.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.1581 to $0.1841 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This Form 4 is filed as an amendment to a transaction already disclosed in Table I of the reporting person's Form 4 of 1/5/18. This amendment corrects the range of prices listed in Footnote 2 to Column 4 and makes no other changes.